Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent.

Autor:	Yun-Zhao Tang1, Gang Wang1, Zhen-Huan Jiang1, Tian-Tian Yan1, Yi-Jun Chen1, Min Yang1, Ling-Ling Meng1, Yan-Juan Zhu1, Chen-Guang Li1, Zhu Li1, Ping Yu1, Chang-Lin Ni1 ncl1959@163.com
Zdroj:	Diabetology & Metabolic Syndrome. 10/19/2015, Vol. 7, p1-9. 9p. 1 Diagram, 2 Charts, 3 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu